Entering text into the input field will update the search result below

FDA approves Merck, Sanofi pediatric vaccine

Dec. 26, 2018 2:57 PM ETSanofi (SNY) StockMRK, SNYBy: Brandy Betz, SA News Editor8 Comments
  • The FDA approves Vaxelis, a pediatric hexavalent combination vaccine developed as a JV between Sanofi (SNY +0.2%) and Merck (MRK +2%).
  • The vaccine is indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b in patients aged 6 weeks to 4 years.
  • The companies are working to maximize production to meet U.S. demand will a commercial launch happening no sooner than 2020.

Recommended For You

About SNY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SNY--
Sanofi